Ametop 40 mg/g Gel

  • Name:

    Ametop 40 mg/g Gel

  • Company:
    info
  • Active Ingredients:

    Tetracaine hydrochloride

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/05/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 10/5/2019

Click on this link to Download PDF directly

Alliance Pharmaceuticals Ireland

Alliance Pharmaceuticals Ireland

Company Products

Medicine NameActive Ingredients
Medicine Name Ametop 40 mg/g Gel Active Ingredients Tetracaine hydrochloride
Medicine Name Anbesol Anaesthetic Antiseptic Oromucosal Solution Active Ingredients Cetylpyridinium Chloride, Chlorocresol, Lidocaine Hydrochloride
Medicine Name Haemopressin 1 mg powder and solvent for solution for injection Active Ingredients Terlipressin acetate
Medicine Name Naseptin Nasal Cream Active Ingredients Chlorhexidine Dihydrochloride, Neomycin sulfate
Medicine Name Nu-Seals 300 Active Ingredients Aspirin
Medicine Name Nu-Seals 75 Active Ingredients Aspirin
Medicine Name Occlusal Active Ingredients Salicylic Acid
Medicine Name Quinoderm 10% w/w + 0.5% w/w Cream Active Ingredients Benzoyl Peroxide, hydrous, Potassium hydroxyquinoline sulfate
Medicine Name Quinoderm 5% w/w + 0.5% w/w Cream Active Ingredients Benzoyl Peroxide, hydrous, Potassium hydroxyquinoline sulfate
Medicine Name Ranitidine 50mg/2ml Solution for Injection and Infusion Active Ingredients Ranitidine Hydrochloride
Medicine Name Syntometrine injection Active Ingredients Ergometrine Maleate, Oxytocin
1 - 0 of 11 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 10 May 2019 PIL

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 10 May 2019 SmPC

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

  • Section 4.8 Undersirable effects - Amendment to adverse event reporting information.

Updated on 22 March 2019 PIL

Reasons for updating

  • New PIL for new product

Updated on 22 March 2019 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Supply through pharmacy only

Updated on 20 July 2018 SmPC

Reasons for updating

  • File format updated to PDF

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

File format update to PDF

Updated on 17 July 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only